Biotech entity
Every one of those 1 sits in a single category, pharma. Dadachanji Group is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention KAISHA Pharma, all published on September 4, 2026.
Last mentioned: Sep 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Dadachanji Group is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention KAISHA Pharma, all published on September 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering KAISHA Pharma. Shared-story counts are live from our verified record — not editorial picks.
KAISHA Pharma launch announced
Dadachanji Group announces the launch of KAISHA Pharma with an initial 45 million investment and a manufacturing footprint of more than 300,000 square feet.
KAISHA Pharma enters the injectables packaging market with a 45M initial investment and more than 300,000 sq ft of manufacturing capacity, targeting biologics and advanced therapeutics with specialty glass containment and ready-to-use formats.
KAISHA Pharma is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
